Clinical Trial Update: Phase II Single Arm Trial of Low Dose Capecitabine in Patients With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

Phase II single-arm trial evaluating low-dose capecitabine in patients with metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Metastatic Breast Cancer | Phase 2 | Status: RECRUITING